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Introduction: Radial endobronchial ultrasonography miniprobe 
(rEBUS-MP) is a technique that has increased the diagnostic yield of 
bronchoscopic occult pulmonary lesions. The purpose of this study was 
to identify computed tomography (CT) characteristics affecting the suc-
cess rate of rEBUS-MP in the evaluation of these pulmonary lesions.
Methods: Our study encompassed a retrospective review of all con-
secutive patients who underwent a rEBUS-MP examination between 
January 2011 and December 2013. CT characteristics including 
lesion size, lesion location, and bronchus sign were analyzed against 
two defined outcomes (visualization yield and diagnostic yield). 
Univariate analysis was employed to examine the individual effects 
of each CT parameter on visualization yield and diagnostic yield. 
Multivariate logistic regression was performed to identify significant 
predictors of diagnostic yield.
Results: Seven hundred and sixty lesions (760 patients) were 
included. The mean ± SD longest lesion diameter was 43 ± 2 mm. 
rEBUS-MP could visualize 83% and a definitive diagnosis was 
established in 62%. In a multivariate analysis, longest lesion diameter 
greater than 20 mm (odds ratio [OR]: 1.97 and p = 0.036), distance 
lesion to secondary or tertiary carina greater than 40 mm (OR: 0.60 
and p=0.016), and lobar segment (1, 3, or 6, respectively) were deter-
mined to be significant factors predicting diagnostic yield. Bronchus 
sign was the only parameter that indirectly influenced the diagnostic 
yield through enhancing visualization yield (p < 0.001).
Conclusion: Multivariate analysis revealed that lesion size, distance 
to carina, and segment were predictors of diagnostic yield. The pres-
ence of a bronchus sign substantially increased the diagnostic yield 
through the visualization yield.
Key Words: Diagnosis, Pulmonary lesion, Radial endobronchial 
ultrasonography.
(J Thorac Oncol. 2015;10: 472–478)
The diagnosis of a pulmonary lesion that is present beyond the endoscopically visualized bronchi using a conven-
tional flexible videobronchoscope (outer diameter 5–6 mm) 
is clinically challenging1–2. Advances in bronchoscopic and 
navigation techniques have allowed clinicians to provide a 
continued increase in the diagnostic yield of the endoscopic 
procedure. The assessment of pulmonary lesions consists of 
the manual inspection of multidetector computed tomography 
(CT) images to establish a mentally driven route toward the 
lesion followed by a live bronchoscopy with radial endobron-
chial ultrasound miniprobe (rEBUS-MP) to approach endo-
scopically occult pulmonary lesions. A recent meta-analysis 
reported a diagnostic yield of 71% (95% confidence interval 
[CI]: 67–76%) for bronchoscopy with rEBUS-MP-guided 
transbronchial lung biopsy (TBLB) of endoscopically occult 
pulmonary lesions 3. The complication rate of this rEBUS-MP-
guided TBLB is extremely low as compared with traditional 
transthoracic needle biopsy or surgical sampling techniques, 
with a pooled rate of chest drainage for pneumothorax of only 
0.4%4. Other new guided bronchoscopy techniques, such as 
electromagnetic navigation, virtual bronchoscopic navigation, 
and ultrathin bronchoscopy reach a similar diagnostic yield of 
approximately 70%3,5. Apart from the effects of operational 
differences at various institutions, the diagnostic yield of these 
new technologies is considerably affected by CT characteris-
tics of the investigated pulmonary lesion.6–10 The consequence 
might be that the diagnostic method to reach and biopsy a pul-
monary lesion could be based on lesion location, lesion size, 
and/or expertise available.
We designed a retrospective study to evaluate the CT 
characteristics that might influence the diagnostic yield of 
EBUS-MP-guided TBLB of a pulmonary lesion and to pro-
pose an algorithm to approach an endoscopic occult parenchy-
mal pulmonary lesion.
PATIENTS AND METHODS
Patients
Between January 1, 2011 and December 31, 2013, 760 
patients with an endoscopically invisible pulmonary lesion 
underwent an EBUS procedure with a radial ultrasonic mini-
probe for diagnostic purpose in a single center. Exclusion 
criteria for a rEBUS-MP procedure consisted of suspected 
bronchopneumonia, solid lesions less than 10 mm largest diam-
eter calculated on lung windows from axial CT images, ground 
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glass opacity (pure or part-solid less than 50%) lesions, and solid 
lesions less than 15 mm largest diameter touching the visceral 
pleura. The institutional review board of University Hospitals 
KU Leuven approved this retrospective study (S56813).
CT analysis
The CT images of these 760 patients were retrospec-
tively reviewed. All CT examinations were made with 64 slice 
multidetector CT scanners (Siemens, Germany; Philips, The 
Netherlands) using a standardized contrast-enhanced imag-
ing protocol. Patients were scanned in the supine position in 
craniocaudal direction at end-inspiration. The scan parameters 
were as follows: 120 kVp, 85 mAs, and 1 mm scanning thick-
ness. The axial images (5 mm thickness) and coronal images 
(3 mm thickness) were reconstructed using B30f kernel for 
mediastinal algorithm and B50f kernel for lung algorithm. 
Images were transferred to a PACS workstation (AGFA) and 
IMPAX Volume viewing 3.0 software (AGFA HealthCare NV, 
Mortsel, Belgium) was used for analysis. CT images were 
evaluated for the presence of bronchus sign, lesion size, and 
lesion location. A bronchus sign is the finding on cross-section 
of a bronchus leading directly to or contained within a nodule 
or mass11. Measurements were performed on lung window set-
tings. First, we identified on axial CT images (Fig. 1A) the 
longest lesion diameter (LLD) and the longest perpendicular 
lesion diameter (LPLD), and thereafter on coronal CT images 
(Fig. 1B) the largest apicocaudal diameter (LAD). Location of 
the lesion within the lung was determined by lobe, lobar seg-
ment, and by measuring the distance between the lesion and 
the secondary (for right upper lobe, left upper lobe, and left 
lower lobe) or tertiary (for right middle lobe and right lower 
lobe) carina (Dcarina) using IMPAX volume viewing software 
(Fig. 1C). The distance from lesion to the chest wall (Dthorax) 
was measured on axial CT images as the shortest distance 
between the lesion and the chest wall (Fig. 1A).
Bronchoscopy.
After informed consent videobronchoscopy was per-
formed using an Olympus BF-1T160 or BF-160 with outer diam-
eter 5.2–6.0 mm and working channel 2.0–2.8 mm or a Fujinon 
EB-530T or EB-530S with outer diameter 4.9–5.8 mm and work-
ing channel 2.0–2.8 mm, which can visualize up to fourth- to 
sixth-order of bronchi. Whenever no lesion was present within 
the endoscopically visualized bronchi, endobronchial ultrasonog-
raphy was performed using an endobronchial ultrasound system 
(processor EU-M20 and driving unit MH-240; Olympus, Japan) 
equipped with a 20-MHz mechanical radial miniprobe (UM-S20-
20R; Olympus). The bronchoscopist inspected in advance the 
axial and coronal CT scan images to establish a mentally driven 
route toward the lesion. During bronchoscopy, the lesion was 
FIGURE 1.  The primary tumor is 
located in segment 2 of the left upper 
lobe on computed tomography. A, 
The lesion was 34.8 mm in LLD and 
28.0 mm in LPLD measured on axial 
CT images, while located 40.9 mm 
from the chest wall (Dthorax). B, The 
lesion was 33.1 mm in LAD mea-
sured on coronal CT images. C, The 
lesion was located 54.1 mm from the 
secondary carina (Dcarina) measured 
by volume viewing software (AGFA 
HealthCare NV, Mortsel, Belgium). 
LLD, longest lesion diameter; LPLD, 
longest perpendicular lesion diameter; 
CT, computed tomography; LAD, 
longest apicocaudal diameter.
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accessed by randomly passing the rEBUS-MP into the mentally 
selected (sub)segmental bronchi without fluoroscopic or naviga-
tional guidance. After detection of the lesion by the rEBUS-MP, 
the bronchoscope was kept in place at the nearest visible subseg-
mental carina and the rEBUS-MP was removed while measur-
ing the distance between the detected lesion and the tip of the 
bronchoscope. This was considered the ‘rEBUS-MP measure-
ment method’. Thereafter, a marked biopsy forceps (single-use 
Radial Jaw 2.0 mm biopsy forceps, Boston Scientific, USA) was 
introduced into the target (sub)segmental bronchus for a distance 
as measured and marked on the forceps, and at least five forceps 
TBLB were taken for histological analysis12. Neither X-ray fluo-
roscopy- nor EBUS-guided sheath were used.
EBUS-MP-guided TBLB samples were considered 
diagnostic when a specific histopathological diagnosis was 
consistent with the clinical presentation and no further invasive 
diagnosis or follow-up was required. The diagnostic yield was 
calculated from this assessment. In case of normal findings or 
a nonspecific inflammation on microscopy, the final specific 
diagnosis was based on an additional invasive biopsy (percu-
taneous core needle or surgical biopsy) when appropriate and/
or radiologic follow-up of at least 6 months. The diagnostic 
sensitivity (true positive/(true positive + false  negative)) of a 
TBLB could be calculated from the final specific diagnosis.
Statistical Analysis
Data analysis was performed using SPSS statistical 
software (IBM SPSS Statistics 20; Chicago, IL). Continuous 
variables were analyzed using one-way anova, and dichoto-
mous variables were analyzed with Fisher’s exact test, as 
appropriate. A multivariate logistic regression was performed 
to identify the significant predictors of the diagnostic yield (p 
< 0.05). Multivariate logistic regression was used to identify 
the independent variables contributing to statistical signifi-
cance. The OR and associated 95% CI CI were determined to 
assess the contributions of significant factors. In the multiple 
logistic regression model, we have used the Variance Inflation 
Measures to check whether there was multicollinearity for the 
proposed model. All reported p values were two-sided, and a 
p value less than 0.05 was considered statistically significant.
RESULTS
Demographics
A total of 760 lesions in 760 patients (490 men and 270 
women; mean age 67 years) were examined. A total of 639 
(84%) lesions were detected by rEBUS-MP, and a definitive 
pathological diagnosis was established in 471 (62%) lesions 
by rEBUS-MP-guided TBLB (Table 1). The lobar location of 
the pulmonary lesions was variously distributed: 220 in the 
right upper lobe, 37 in the right middle lobe, 155 in the right 
lower lobe, 215 in the left upper lobe, and 133 in the left lower 
lobe (Table 1). The mean ± SD LLD and LPLD on axial CT 
images were 43 ± 2 and 25 ± 1 mm, respectively. The mean 
± SD LAD on coronal CT images and mean ± SD Dthorax 
on axial CT images were 26 ± 1 and 22 ± 2 mm, respectively. 
The mean ± SD Dcarina on 3D-CT scan was 55 ± 2 mm. A 
bronchus sign was present in 618 (81%) lesions. The entire 
study group consisted of 555 (73%) malignant lesions and 
205 (27%) benign lesions (Table 2). The proportion of benign 
lesions visualized by rEBUS-MP was 77%, but its diagnos-
tic yield of TBLB was only 36%. Benign lesions with a spe-
cific diagnosis based on TBLB (n = 74) included mainly COP, 
sarcoidosis, mycobacterial and fungal infection, lymphocytic 
interstitial pneumonia, hamartoma and Wegener’s granuloma-
tosis. The proportion of malignant lesions detected by rEBUS-
MP was 87%, and its diagnostic yield of rEBUS-MP-guided 
TBLB was 72%. A pneumothorax occurred in nine patients 
(pneumothorax rate 1.2%) of whom one patient required an 
intercostals catheter drainage.
Univariate Analysis
Univariate analysis of several CT scan characteristics 
(bronchus sign, lesion location, and lesion size) in relation to 
the rEBUS-MP visualization yield and guided TBLB diag-
nostic yield are displayed in Table 1. Bronchus sign was sig-
nificantly associated with visualization yield and diagnostic 
yield. EBUS-MP detected 97% of the pulmonary lesions with 
a bronchus sign on CT scan, and the guided TBLB finally diag-
nosed 72% of the pulmonary lesions with a bronchus sign. No 
association was observed between most elements of location 
(lobar location, segmental location, or Dthorax) and visualiza-
tion yield, but a statistically significant association was observed 
between decreasing Dcarina and both visualization and diagnos-
tic yield. The LLD on axial CT images was significantly asso-
ciated with both visualization and diagnostic yield. The LPLD 
on axial images and LAD on coronal CT images were strongly 
associated with visualization and diagnostic yield, but these 
parameters were strongly correlated with LLD (r = 0.80 [95% 
CI: 0.77–0.83] and r = 0.78 [95% CI 0.75–0.81], respectively).
A strong association (p < 0.001) was observed between 
EBUS-MP visualization yield and guided TBLB diagnostic 
yield. 73% of visualized lesions were diagnosed. Only 2% 
of undetected lesions were diagnosed. These 2% undetected 
cases corresponded to two patients in whom a parenchymal 
bronchial occlusion was assumed as the rEBUS-MP could not 
be forwarded and therefore TBLB were taken at that distance.
Multivariate Analysis
The result of the multivariate logistic regression anal-
ysis indicating significant predictors of the diagnostic yield 
is depicted in Table 3. Our study identified four factors that 
directly had a statistically significant impact on the diagnos-
tic yield of rEBUS-MP-guided TBLB: LLD cutoff 20 mm 
(p = 0.036), distance lesion to carina cutoff 40 mm (p = 0.016), 
and segments 1, 3, or 6 (p < 0.010, in reference to all other 
segments). Bronchus sign was the only parameter that indi-
rectly influenced the diagnostic yield through enhancing visu-
alization yield (p < 0.001; Fig. 2).
A longest lesion diameter greater than 20 mm was more 
likely (OR: 1.97) to lead to a definite pathological diagnosis 
than a LLD less than or equal to 20 mm. A Dcarina greater than 
40 mm was less likely (OR: 0.60) to induce a definite patho-
logical diagnosis compared with a Dcarina less than or equal 
to 40 mm. A pulmonary lesion located in segment 1, 3, or 6 
resulted in a significantly higher diagnostic yield compared 
475Copyright © 2014 by the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology ®  •  Volume 10, Number 3, March 2015 CT Characteristics [NG1] for rEBUS Diagnosis
with the other segments (OR: 2.32 and p = 0.002; OR: 2.28 
and p = 0.004; OR: 1.93 and p = 0.009, respectively).
DISCUSSION
The primary aim of our study was to explore whether CT 
characteristics can affect the success rate of rEBUS-MP-based 
evaluation of a bronchoscopically occult pulmonary lesion. Our 
large retrospective study showed that a LLD greater than 20mm, 
a distance from lesion to the carina less than or equal to 40 mm, 
and segmental location (segments 1, 3, or 6) more likely lead to 
a definitive diagnosis based on rEBUS-MP-guided TBLB. The 
distance to the secondary or tertiary carina has a direct impact 
on the number of divisions or bronchial generations, and the 
size of the lesion has a direct impact on the number of bron-
chi reaching the lesion. Although these parameters had a direct 
effect on the diagnostic yield, the presence of a bronchus sign 
on the CT scan had the highest impact on the diagnostic yield 
through an increased visualization yield (Fig. 2).
TABLE 1.  Univariate Analysis for Visualization and Diagnostic Yield for CT Images Characteristics of Bronchus Sign, Location, and Size
EBUS-MP Visualization Yield EBUS-TBLB Diagnostic Yield
N Detected, n (%) Not Detected, n p Value N Diagnostic, n (%) Not Diagnostic, n p Value
Patients 760 639 (84%) 121 <0.001 760 471 (62%) 289 <0.001
Bronchus sign
  Absent 142 41 (29%) 101 <0.001 142 29 (20%) 113 <0.001
  Present 618 598 (97%) 20 618 424 (72%) 176
Location
  Lobe 0.413 0.937
   Right upper lobe 220 183 (83%) 37 220 166 (76%) 52
   Right middle lobe 37  33 (89%) 4 37 27 (73%) 10
   Right lower lobe 155 137 (89%) 18 155 119 (20%) 35
   Left upper lobe 215 177 (82%) 38 215 161 (28%) 54
   Left lower lobe 133 109 (82%) 24 133 103 (18%) 30
  Segment 0.149 0.017
   1 136 107 (79%) 29 136 88 (65%) 48
   2 151 124 (82%) 27 151 88 (58%) 63
   3 109  96 (88%) 13 109 77 (71%) 32
   4 and 5 78  67 (86%) 11 78 41 (53%) 37
   6 143 126 (88%) 17 143 100 (70%) 43
   7 and 8 43  39 (91%) 4 43 26 (61%) 17
   9 44  37 (84%) 7 44 24 (55%) 20
   10 56  43 (77%) 13 56 27 (48%) 29
  DCARINA (mm) <0.001 <0.001
   ≤30 136 125 (92%) 11 136 101 (74%) 35
   >30 624 514 (82%) 110 624 370 (59%) 254
   ≤40 212 195 (92%) 17 212 157 (74%) 55
   >40 548 444 (81%) 104 548 313 (57%) 234
   ≤50 311 282 (90%) 29 311 219 (70%) 92
   >50 449 357 (70%) 92 449 252 (56%) 197
   ≤60 426 381 (89%) 45 426 293 (69%) 133
   >60 334 258 (77%) 76 334 178 (53%) 156
   Mean ± SD All 53 ± 2 mm 67 ± 6 mm <0.001 All 51 ± 2 mm 61 ± 3 mm <0.001
  DTHORAX (mm) 0.456 0.630
   ≤0 242 212 (88%) 30 242 159 (66%) 83
   >0 518 427 (82%) 91 518 312 (60%) 206
   ≤5 265 229 (86%) 36 265 171 (65%) 94
   >5 495 410 (83%) 85 495 300 (61%) 195
   ≤10 301 257 (85%) 44 301 189 (63%) 112
   >10 459 382 (83%) 77 459 282 (61%) 177
   Mean ± SD All 22 ± 2 mm 24 ± 4 mm 0.456 All 22 ± 2 mm 23 ± 3 mm 0.630
(Continued)
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The posthoc aim was to establish an algorithm to 
approach a pulmonary lesion. As the diagnostic performance 
of rEBUS-MP-guided TBLB is directly influenced by the 
lesion location and the lesion size, we divided our entire study 
cohort into three patient groups based on axial CT images 
(Table 4). Group 1 represented ‘peripheral small’ defined 
as a lesion on CT scan characterized by a Dthorax = 0 mm 
together with a LLD of less than or equal to 30mm. Group 
2 represented ‘central small’ defined as a lesion on CT scan 
characterized by a Dthorax greater than 0 mm together with a 
LLD of less than or equal to 30 mm. Group 3 represented ‘any 
large’ defined as a lesion on CT scan characterized by a LLD 
of greater than 30 mm (Fig. 1). The cutoff at 30 mm for small 
versus large lesion is based on relevant clinical elements, such 
as T1 category by the International Association for the Study 
of Lung Cancer tumor, node, metastasis system, the defini-
tion of a solitary pulmonary nodule, and the observed high-
est differential rate between visualization yield and diagnostic 
sensitivity. The visualization yield and diagnostic sensitivity 
of 72 and 57%, respectively, were suboptimal for lesions allo-
cated to group 1 and we might suggest a CT-guided percuta-
neous core needle biopsy as the preferred invasive diagnostic 
test based upon a favorable diagnostic yield to pneumothorax 
ratio13–14. The visualization yield and diagnostic sensitivity 
of 69% and 53%, respectively, were suboptimal for lesions 
allocated to group 2, but we believe that we can improve 
the visualization and diagnostic yield by applying modern 
bronchoscopic techniques (e.g., ultrathin bronchoscope or a 
guided sheath technique) and/or navigation tools (e.g., virtual 
bronchoscopy)15–17. Finally, we consider a visualization yield 
and diagnostic sensitivity of 91 and 81%, respectively, accept-
able for lesions allocated to group 3 and assessed by a conven-
tional bronchoscope with guided TBLB after a ‘rEBUS-MP 
measurement method’.
It has been established that a strong correlation exists 
between rEBUS-MP visualization yield and diagnostic yield6–
10, 18–20. A reported rEBUS-MP visualization yield of 74–93% 
and diagnostic yield of 58–87% for bronchoscopically occult 
pulmonary lesions implicates that the visualization yield 
is 10–20% higher than the diagnostic yield. Our result is in 
line with this observation, as rEBUS-MP led to visualization 
of 83% of the pulmonary lesions and a specific diagnosis in 
62% of the pulmonary lesions (Table 1). Factors such as sam-
pling error (no guided sheath used; lesion tangential to the 
bronchus), prevalence of benign disease (which is less likely 
diagnosed by TBLB alone), and the applied definition of a 
Size
  LLD (mm) <0.001 <0.001
   ≤10 4  3 (75%) 1 4 2 (50%) 2
   >10 756 636 (84%) 120 756 469 (62%) 287
   ≤20 81  46 (57%) 35 81 28 (35%) 53
   >20 679 593 (87%) 86 679 443 (65%) 236
   ≤30 243 168 (69%) 75 243 110 (45%) 133
   >30 517 471 (91%) 46 517 361 (70%) 156
   Mean ± SD All 46 ± 2 mm 29 ± 3 mm <0.001 All 47 ± 2 mm 36 ± 2 mm <0.001
  LAD (mm) <0.001 <0.001
   ≤10 54 32 (59%) 22 54 23 (43%) 31
   >10 706 607 (86%) 99 706 448 (63%) 258
   ≤20 324 241 (75%) 83 324 164 (51%) 160
   >20 436 398 (91%) 38 436 307 (70%) 129
   ≤30 543 432 (80%) 111 543 308 (57%) 235
   >30 217 207 (95%) 10 217 163 (75%) 54
   Mean ± SD All 27 ± 1 mm 18 ± 2 mm <0.001 All 28 ± 2 mm 22 ± 1 mm <0.001
  LPLD (mm) <0.001 <0.001
   ≤10 47 26 (55%) 21 47 18 (38%) 29
   >10 713 613 (86%) 100 713 453 (64%) 260
   ≤20 326 240 (74%) 86 326 161 (49%) 165
   >20 434 399 (92%) 35 434 310 (71%) 124
   ≤30 538 427 (80%) 111 538 305 (57%) 233
   >30 222 212 (96%) 10 222 166 (75%) 56
Mean ± SD All 27 ± 1 mm 18 ± 2 mm <0.001 All 28 ± 1 mm 22 ± 1 mm <0.001
CT, computed tomography; EBUS-MP, endobronchial ultrasound miniprobe; TBLB, transbronchial lung biopsy; LPLD, longest perpendicular lesion diameter; LAD, longest 
apicocaudal diameter.
TABLE 1.  (Continued)
EBUS-MP Visualization Yield EBUS-TBLB Diagnostic Yield
N Detected, n (%) Not Detected, n p Value N Diagnostic, n (%) Not Diagnostic, n p Value
477Copyright © 2014 by the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology ®  •  Volume 10, Number 3, March 2015 CT Characteristics [NG1] for rEBUS Diagnosis
‘specific diagnosis’ are suggested factors responsible for this 
20% differential yield between visualization and diagnosis.
The major limitations of our study are its retrospective 
nature and applied methodology. First, we tried to minimize 
patient selection bias by including all consecutive patients 
who have undergone a rEBUS-MP investigation at our center 
between January 2011 and December 2013. It should be stressed 
that solid lesions less than 10 mm surrounded by lung paren-
chyma and solid lesions less than 15 mm touching the visceral 
pleura were excluded for a rEBUS-MP investigation. Second, 
we adopted a homogenous rEBUS-MP methodology with 
guided forceps TBLB tissue sampling without using additional 
auxiliary tools, such as a guided sheath, bronchial brushing or 
washing, X-ray fluoroscopy, or virtual navigation techniques, 
which might positively impact on the diagnostic yield. Third, 
the diagnostic yield of small bronchoscopic TBLB depends on 
the determined criteria for a specific diagnosis and should not 
be tenuous. Therefore, the authors did not accept the diagnosis 
of nonspecific inflammation as a specific diagnosis even when 
the treating physician decided to follow-up the patient based on 
the combined TBLB result and clinical features. Fourth, for the 
primary end point of our study, we decided to evaluate the diag-
nostic yield instead of the diagnostic sensitivity of rEBUS-MP-
guided TBLB. This was decided given the suboptimal negative 
predictive value of 0.37 (95% CI: 0.31–0.43) for TBLB.
In conclusion, our study revealed that lesion size, dis-
tance to secondary or tertiary carina, and segment are signifi-
cant direct predictors of the diagnostic yield in bronchoscopy 
occult pulmonary lesions, whereas bronchus sign had a sig-
nificant impact through an increased visualization yield.
TABLE 3.  Multivariate Logistic Regression Analysis of Factors Leading to a Definitive Diagnosis Based on rEBUS-MP-guided TBLB
Variable Contrast B SE Odds Ratio OR 95% CI p Value
LLD Largest lesion diameter > vs ≤ 20 mm 0.676 0.322 1.965 1.045–3.695 0.036
DCARINA Dcarina > vs ≤40 mm -0.509 0.212 0.601 0.397–0.911 0.016
SEGMENT Segment 1 vs all other segments 0.839 0.275 2.315 1.351–3.967 0.002
Segment 3 vs all other segments 0.823 0.285 2.278 1.303–3.984 0.004
Segment 6 vs all other segments 0.657 0.252 1.928 1.177–3.160 0.009
rEBUS-MP Detected vs not detected 5.054 0.724 156.671 37.90–674.69 <0.001
TBLB, transbronchial lung biopsy; OR, odds ratio; CI, confidence interval; LLD, longest lesion diameter; DCARINA, distance between lesion and carina; rEBUS-MP, radial 
endobronchial ultrasound miniprobe; SE, standard error..
TABLE 2.  Characteristics of 760 Study Patients Referred for Radial EBUS-MP Bronchoscopy
Final Diagnosis, Characteristics
Proportion of  
Lesions, n (%).
Visualization Yield for 
rEBUS-MP, n (%)
Diagnostic Yield for 
TBLB, n (%)
Malignant lesions 555/760 (73%) 481/555 (87%) 397/555 (72%)
  NSCLC 480 419 (76%) 350 (63%)
   Adenocarcinoma 245 216 (88%) 189 (77%)
   Squamous cell Ca 124 111 (90%) 99 (80%)
   NSCLC-NOSa 96 78 (81%) 51 (53%)
   LCNEC 1 1 (100%) 1 (100%)
   AdenoSquamous cell Ca 5 5 (100%) 4 (80%)
   Carcinoid 9 8 (89%) 6 (67%)
  SCLC 32 30 (94%) 27 (84%)
  Meta extrathoracic Ca 37 26 (70%) 15 (41%)
  Lymphoma 6 6 (100%) 5 (83%)
Benign lesions 205/760 (27) 158/205 (77%) 74/205 (36%)
  Sarcoidosis 19 18 (95%) 12 (63%)
  Fungal disease 5 4 (80%) 3 (60%)
  COP 38 37 (97%) 30 (79%)
  Wegener 5 5 (100%)  2 (40%)
- Otherb 138 94 (68%)  27 (20%)
aCombination of pathological proven NSCLC-NOS and lesions without a pathological proof but suspected for lung cancer and as such treated with radiotherapy based on a 
multidisciplinary tumor board decision.
bPneumonia (n = 8), hamartoma (n = 2), mycobacterium species (n = 10), lymphocytic interstitial pneumonia (n = 5), rheumatoid lung nodule (n = 2), extrinsic allergic alveolitis 
(n = 1), meningioma (n = 1), solitary fibrous tumor (n = 1), and aspecific inflammation (n = 108).
n, number; TBLB, transbronchial lung biopsy; NSCLC, non–small-cell lung cancer; NOS, not otherwise specified; LCNEC, large cell neuro-endocrine carcinoma; SCLC, small 
cell lung cancer; COP, cryptogenic organizing pneumonia; rEBUS-MP, radial endobronchial ultrasound miniprobe.
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FIGURE 2.  Schematic presentation of factors hav-
ing a significant impact on the diagnostic yield of 
rEBUS-MP-guided TBLB. TBLB, transbronchial lung 
biopsy; rEBUS-MP, radial endobronchial ultrasound 
miniprobe.
TABLE 4.  Posthoc Patient Grouping Based on Axial 2D-CT Images
CT characteristics of 
Pulmonary Lesion n of Patients Prevalence Malignancy Visualization Yield Diagnostic Yield Diagnostic Sensitivity
Group 1 ‘peripheral small’ 32 69% 72% 50% 57%
Group 2 ‘central small’ 211 71% 69% 45% 53%
Group 3 ‘any large’ 517 74% 91% 70% 81%
CT, computed tomography; n, number.
